Cancer Genetics

Papers
(The TQCC of Cancer Genetics is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-03-01 to 2025-03-01.)
ArticleCitations
Multi-omics inference of differential breast cancer-related transcriptional regulatory network gene hubs between young Black and White patients43
PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas22
A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies21
88. Significant association of BRCA1, BRCA2 and TP53 gene polymorphisms with breast cancer risk in Khyber Pakhtunkhwa, Pakistan20
Comprehensive FISH testing using FFPE tissue microarray of primary lymph node tissue identifies secondary cytogenetic abnormalities in Mantle Cell Lymphoma19
Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment18
A mechanistic insight into cancer progression mediated by Nucleoporins18
A 10-gene-methylation-based signature for prognosis prediction of colorectal cancer15
Interpretative differences of combined cytogenetic and molecular profiling highlights differences between MRC and ELN classifications of AML14
24. Methylation sequencing enhances interpretation of clonal hematopoiesis dynamics13
43. Challenges of classifying variants associated with disorders of somatic mosaicism and guideline creation12
23. Detection of somatic tumor mutations in circulating plasma DNA of patients with sellar and skull base tumors12
40. Prioritization of defining and supportive diagnostic variants in pediatric tumors12
25. Enhancing precision oncology: The value of open-source knowledgebase integration12
2. Diagnostic next generation sequencing to detect MYD88 L265P in lymphoplasmacytic lymphoma compared to ddPCR11
42. Piloting NTRK fusion-specific oncogenicity guidelines: Lessons learned11
11. Developing a robust bioinformatics workflow to support personalized neoantigen vaccine clinical trials10
69. Expert consensus standardization of FGFR3 SNV oncogenicity classification and interpretation10
76. Automating immunogenomic tumor board decision-making for neoantigen cancer vaccine design10
64. A rare finding of triple KRAS mutations with OmniSeq® INSIGHT in a patient with colorectal adenocarcinoma9
Pan-cancer analysis reveals that CTC1-STN1-TEN1 (CST) complex may have a key position in oncology8
Editorial Board8
74. Dilemma of selecting the optimal diagnostic test(s) for genetic biomarkers in hematologic malignancies8
A pediatric BAL case with double Ph chromosomes and trisomy 58
A Case report: Co-occurrence of IMAGe syndrome and Rhabdomyosarcoma8
60. Panning for neoantigens to demonstrate feasibility of neoantigen vaccines in canine melanoma7
34. Discovery of circular RNAs through integration of short- and long-read RNA sequencing7
67. Long noncoding RNAs encoding peptides in cancer7
58. Improving the molecular diagnosis of SBDS-related disorders by identifying rare gene conversion events.7
28. Detection of small mutations, copy number alterations and structural variations from targeted cfDNA sequencing in cancer7
68. Integrative analysis of genomic and transcriptomic data using RegTools to identify splice-altering mutations within bulk7
51. Discerning cell types and states in spatial transcriptomics data using topic modelling7
1. Microdeletion 13q12.2 in B cell acute lymphoblastic leukemia: Little but important!7
20. Diagnostic utility and lessons learned from deep sequencing vascular malformations6
28. Identification of TP53 germline variants in pediatric patients undergoing tumor testing6
43. Adapting CIViC, a cancer variant interpretation knowledgebase, to support variants in disorders of somatic mosaicism6
29. Launching a CGC initiative to support trainees and early career members: Survey results and analysis6
49. Clinical validation of Infinium CytoSNP-850K SNP-Array for routine copy number profiling of hematological malignancies6
17. Multi-consortia initiative to standardize the representation and curation of oncogenic fusions6
34. A molecular and clinicopathologic analysis of primary intracranial sarcomas6
48. Crowdsourcing expert curation of somatic variants by the ClinGen Somatic Hematologic Cancer Taskforce6
123. Chromosomal microarray assists interpretation of cytogenetic abnormalities in hematopoietic malignancies5
Editorial Board5
4. ETV6-ABL1 variant rearrangement described in a childhood ALL patient5
21. A case of acute myeloid leukemia with gain of two copies of neocentromeric chromosome 115
30. Characterization of atypical iAMP21 observed in B-Lymphoblastic Leukemia (B-ALL): a 2.5-year retrospective study from the Mayo Clinic5
44. Reevaluation of copy number variant (CNV) classifications in the clinical laboratory setting: challenges, insights, and experiences with a laboratory-initiated process5
134. Novel fusions in aggressive infant sarcomas: Expanding the scope of 'CIC-rearranged' sarcoma without CIC rearrangement5
Editorial Board5
121. Single cell TCR sequencing identifies an enriched V(D)J repertoire in canine melanoma5
43. Structural changes characterized by whole genome mate-pair sequencing in a case with ETV6/ABL1 gene fusion and atypical Chronic Myeloid Leukemia5
22. Masked hypodiploid B-Cell Lymphoblastic Leukemia (B-ALL) characterized by SNP microarray in a Li Fraumeni syndrome patient with post therapy karyotype changes5
35. Frequencies of Turner syndrome abnormalities as detected by high resolution chromosomal microarray in products of conception and postnatal blood samples5
51. PS4 utilization for PIK3CA variants implicated in disorders of somatic mosaicism5
135. Tumor deconvolution using comprehensive single-cell RNA sequencing cell type signatures5
High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy5
52. Optical genome mapping and SNP microarray: integrated workflow for optimizing analysis of products of conception5
23. Incidental findings on XON array: Our experience over the last two years5
38. A rare constitutional 13q deletion associated with retinoblastoma and chronic lymphocytic leukemia5
14. Prenatal diagnosis of Acrofacial Dysostosis type 1 (Nager syndrome) by chromosomal microarray at the exon level4
13. HPV forms chimeric virus-human transcripts that affect host gene expression in cervical tumors4
33. Variability in sex and phenotype: Impact of a familial pathogenic DHX37 variant leading to 46,XY gonadal dysgenesis4
32. Genetic testing for individuals with non-syndromic differences in sex development (DSD): collaborative approach yields results4
Acute myeloid leukemia with LRRFIP1::FGFR1 rearrangement and a complex karyotype4
Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions4
83. Cytogenetic and molecular characterization of IDH-mutant adult-type diffuse gliomas with near-total 1p/19q co-deletions4
Detecting the “undetectable” alterations: Use of NGS to uncover high-risk alterations4
9. Implementation survey of the ACMG/CGC standards for interpretation of acquired CNAs and CN-LOH in neoplastic disorders4
76. Von Hippel-Lindau syndrome in a patient with negative germline testing4
81. Prediction of plant based EGFR inhibitors against breast cancer (EGFR) using machine learning model4
89. TCF3::ZNF384 in a Peruvian girl with mixed-phenotype acute leukemia and poor treatment outcome3
26. An ATIC::ALK fusion created by balanced insertion rather than inversion of chromosome 2 in an ALK+ anaplastic large cell lymphoma3
Mast cell leukemia with novel BRAF variant and concomitant atypical KIT variant3
86. Whole genome sequencing of mouse derived cell-free DNA to develop a NF1-MPNST-PDX liquid biopsy model3
64. Utilizing rapid molecular testing to reduce disparities in pediatric cancer in Sub-Saharan Africa3
51. Rare SRY-positive derivative X chromosome in female fetus with apparently normal development3
42. Automated deep aberration detection from chromosome karyotype images3
27. Five-year experience of evaluating individuals at-risk for underlying genetic predisposition to hematologic malignancy3
48. Targeted RNA-Seq on fresh frozen and methanol/acetic acid fixed cells in diagnostic workup of hematologic malignancies3
Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer3
52. ClinGen Pediatric Cancer Taskforce initiatives to advance pediatric clinical interpretations through expert curation3
27. Deregulation and shattering of chromosomal segments containing multiple oncogenic targets in the pathogenesis of diffuse large B cell lymphoma (DLBCL)3
11. Structural variation discovery and interpretation in the era of cytogenomics3
85. Cell-type-specific genotypic interpretation in the human breast3
Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-MYH11 acute myeloid leukemia3
49. A novel method for detection of loss of heterozygosity using B-allele frequency from optical genome mapping data3
41. Resolving ambiguities in copy number variation representation3
90. Genetic biomarkers in pediatric B-cell acute lymphoblastic leukemia detected by NGS in a Peruvian population3
17. Djerba: A modular system to generate clinical genome interpretation reports for cancer3
54. VMD4Kids: A highly sensitive NGS panel to detect low-level mosaic variants in vascular anomalies and overgrowth disorders3
96. A unique case presentation of pediatric spinal ependymoma with chromothripsis of chromosome 6: case report3
TRK inhibitor activity and resistance in TRK fusion-positive cancers in adults3
1. Clinical utility of low-pass whole genome sequencing (LP-WGS) and targeted panel sequencing in liquid biopsies for disease diagnosis and monitoring of patients with pediatric solid tumors3
116. Integrating methylation profiling into adult brain tumor diagnostics - the Australian experience3
66. Screening for genetic predisposition to pediatric leukemia in a Peruvian population3
50. Analysis of gene rearrangements in neoplasms with Hi-C sequencing using fresh-frozen and FFPE specimens3
30. Chromosomal microarray analysis work-up for hypocellular MDS patients with inconclusive cytogenetics3
23. Optical genome mapping reveals new insights into ZFTA fusion in supratentorial ependymomas3
18. Investigation of pathogenic and truncated variants of RUNX1 and DDX41 in All of Us3
56. Whole-exome sequencing identifies somatic mutations penile squamous cell carcinoma3
The clinical aspect of NTRK-fusions in pediatric papillary thyroid cancer2
99. Histopathologic Correlation Somatic Variants in Non Small Cell Lung Cancer with High Tumor Mutation Burden2
74. Genetic and functional characterization of complex chromosomal rearrangements in a family with multisystem anomalies2
Editorial Board2
100. Identification of unique subtypes of pediatric high-grade glioma by comparative tumor transcriptomics2
Dysregulation of metallothionein MT1 sub-types in TCF3::PBX1 pre-B-cell acute lymphoblastic leukemia2
15. Clinical validation of non-invasive prenatal screening using synthetic plasmas2
Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy2
6. Optical genome mapping as a potential Tier1 test for Postnatal Chromosomal Disorders – results of multi-institutional validation study of 331 retrospective clinical samples2
The hsa-miR-516a-5p and hsa-miR-516b-5p microRNAs reduce the migration and invasion on T98G glioblastoma cell line2
Partial tandem duplication of KMT2A gene in patient afflicted with hypereosinophilic syndrome: A case report2
Rare and favorable prognosis of pediatric acute lymphoblastic leukemia with TLS-ERG fusion gene: Case report with long-term follow-up and review of literature2
Editorial Board2
Corrigendum to “Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer” [Cancer Genetics Volumes 2762
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues [Cancer Genetics 268-269 (2022) 137-143]2
Somatic tumor testing implications for Lynch syndrome germline genetic testing2
A rare CALR variant mutation and efficient peginterferon alfa-2a response in a patient with essential thrombocythemia2
34. A rare case of 46,XX/47,XXY mosaic Klinefelter syndrome in an infant2
Mutations of ARID1B, PIK3C2B, KMT2B, and FAT1 genes influence clinical outcome in newly diagnosed myeloma2
28. Trisomy 21 silencing in hematopoietic and neural cells: New insights and prospects2
Selection for or against escape from nonsense mediated decay is a novel signature for the detection of cancer genes2
2. Analytical tools to support detection of homologous recombination deficiency (HRD) using cytogenomic scar markers2
LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185–5p/PLOD1/Akt/mTOR pathway2
Consensus molecular subtyping of colorectal cancers is influenced by goblet cell content2
Molecular determinants of clinical outcomes for anaplastic lymphoma kinase–positive non-small cell lung cancer in Chinese patients: A retrospective study2
RNA profile of immuno‐magnetically enriched lung cancer associated exosomes isolated from clinical samples2
Editorial Board2
82. Enabling large scale precision oncology research with a new standard for genomic variants: OMOP Genomic2
Evaluation of hereditary/familial breast cancer patients with multigene targeted next generation sequencing panel and MLPA analysis in Turkey2
Fibroblast testing can inform medical management in individuals with mosaic variants detected on hereditary cancer panels2
Identification of KMT2A-ARHGEF12 fusion in a child with a high-grade B-cell lymphoma2
31. Rare familial rearrangement with acrocentric satellite material on Yp relocating to Xp in a female fetus2
Whole-exome sequencing in osteosarcoma with distinct prognosis reveals disparate genetic heterogeneity2
13. Remember breakpoint two: Enhancer swapping, a frequent deleterious consequence of balanced chromosomal rearrangements2
A prognostic gene signature for predicting survival outcome in diffuse large B-cell lymphoma2
20. Paternal UPD14 and sSMC derived from chromosome 14: A case report2
MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients2
Case report of a man with multiple paragangliomas and pathogenic germline variants in both NF1 and SDHD2
Evaluation of anti-angiogenic agent F16 for targeting glioblastoma xenograft tumors2
The prognostic significance of FOXC2 gene expression in cancer: A comprehensive analysis of RNA-seq data from the cancer genome atlas1
43. Association between Clonal Hematopoiesis and Inherited Cancer Susceptibility Genes1
24. Clinical utility of mate pair sequencing as a reflex test in B-lymphoblastic leukemia/lymphoma1
5. Further evidence of GABRA4 and TOP3B as autism susceptibility genes1
45. Next-generation cytogenomic characterization of two complex prenatal cases by Saphyr's genome optical mapping1
Clonal cytogenetic abnormalities in donor-derived cells after sex mismatched allogeneic stem cell transplantation1
109. Use of Bionano Optical Genome Mapping in a multi-platform structural variation analysis of a cancer reference cell line1
33. Tumor cellularity estimation in a targeted NGS panel of tumor-only specimens expands analytical utility1
38. Assessment of TRG and TRB clonality by NGS of dermatologic specimens is impacted by biopsy type, DNA and amplicon sizes1
51. Remember breakpoint two. Enhancer swapping, a frequent deleterious consequence of balanced chromosomal rearrangements1
14. Deletions resulting in Brachydactyly Mental Retardation Syndrome (BDMR): Multiple contributing regions in distal 2q371
55. Clinical validation and implementation of exome, transcriptome and whole genome sequencing for pediatric cancers1
57. Developing oncogenicity guidelines for BCR::ABL1-like B-lymphoblastic leukemia/lymphoma through expert consensus1
3. Application of optical genome mapping to identify samples with homologous recombination deficiency1
Distinct mechanisms of PTEN inactivation in dogs and humans highlight convergent molecular events that drive cell division in the pathogenesis of osteosarcoma1
16. International working group recommendations for the implementation of optical genome mapping in Hematologic Malignancies1
Unexpected appearance of KMT2A::MLLT10 fusion transcript in acute myeloid leukemia with t(5;11)(q31;q23.3)1
129. Standardization of cancer terminology in the Mondo Disease Ontology1
103. Defining the pleiotropic GATA2 deficiency phenotype for the development of ACMG-AMP GATA2 variant curation rules1
92. The ClinGen Somatic CDWG supports somatic variant curation and interpretation through structured guidance and procedures1
41. Participant reflections from the program for evaluation of Ashkenazi Jewish Cancer heritability involving the BRCA genes1
53. Re-analysis of reported constitutional copy number variants using the newly published 2019 ACMG/ClinGen Technical Standards reveals few significant interpretation changes1
55. CMA and concurrent karyotyping for MCA, ASD, and/or DD/ID patients: Cost effectiveness based on our 7-year experience1
11. Validation and implementation of BioDot instruments for semi-automated FISH slide processing1
A new four-way complex translocation variant involving the t(8;5;21;4)(q21;q13;q22;q31) and the relocalization of AML1/ETO fusion gene1
40. Correlation of histology, CCND1 over-expression, and CCND1 rearrangement in Renal Cell Carcinomas1
8. A partial deletion of the EP300 gene detected by microarray in an individual with mild autism1
37. Chromosomal microarray in the investigation of ASD: Diagnostic yield of 333 cases1
68. Orthogonal approaches to validate a knowledgebase of interpretations of clinically relevant somatic cancer variants1
52. Variant classification versus variant interpretation: There is a difference1
110. Discovery and characterization of novel fusions in Pediatric B-Lymphoblastic Leukemia (B-ALL)1
33. Optical Genome Mapping identifies additional cytogenetic abnormalities in patients with hematologic malignancies1
48. ALK tissue FISH in lung cancer: The MDACC experience1
14. Concurrent systemic mastocytosis and T-lymphoblastic lymphoma unified by a novel cryptic JAKMIP2::PDGFRB rearrangement1
RNA-Based next generation sequencing complements but does not replace fluorescence in situ hybridization studies for the classification of aggressive B-Cell lymphomas1
56. Variants of established clinical significance: Progress and challenges in the VECS SC-VCEP1
Paediatric B lymphoblastic leukaemia with hyperdiploidy and a false-positive KMT2A fluorescence in situ hybridization result1
High incidence of PI3K pathway gene mutations in South Indian cervical cancers1
8. Harnessing the power of microarray in the analysis of rarer pediatric sarcomas1
105. Machine learning for automated tumor classification based on mutation repertoire1
126. MECOM rearrangement by Pericentric Inversion 3 presents a diagnostic challenge1
104. A hematologic case with germline deletion of PMS2 and increased risk of HNPCC studied by optical genome mapping and NGS1
84. Challenges in the clinical implementation of the large next-generation sequencing oncomine comprehensive plus assay1
61. Clinical whole exome/whole transcriptome analysis detects clinically relevant structural alterations in Multiple Myeloma1
47. Optical genome mapping in hematological malignancy: Clinical outcomes in a 2-year follow-up retrospective study1
Editorial Board1
103. Formation of a ClinGen Variant Curation Expert Panel (VCEP) dedicated to Oncohistone H3 Variants in Pediatric Gliomas1
Importance of conventional cytogenetics in the identification of ins(19;X)(q13.1;p11.2q28) and t(1;11)(q10;p10), both, novel cytogenetic abnormalities in a pediatric AML case1
36. Classifying benign multigenic CNVs: Exploring available population databases1
Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA1
20. Increased Polo-like kinase 1 (Plk1) expression promotes centrosome amplification, chromosomal instability, and tumor formation in a mouse model1
Editorial Board1
25. Large scale analysis in Von Hippel-Lindau disease1
22. Characterization of atypical iAMP21 observed in B-Lymphoblastic Leukemia (B-ALL): A retrospective study from Mayo Clinic1
46. Integrative cytogenetic and molecular studies unmasks `chromosomal mimicry' in hematologic malignancies1
Lynch syndrome and Muir-Torre phenotype associated with a recurrent variant in the 3’UTR of the MSH6 gene1
4. Comprehensive next generation cytogenomics improves risk stratification of acute myeloid leukemia1
Classification of fluorescent R-Band metaphase chromosomes using a convolutional neural network is precise and fast in generating karyograms of hematologic neoplastic cells1
17. Deconvolution of genetic heterogeneity in Glioblastoma using multi-region sampling1
Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs)1
A t(11;14)(q13;q32)/CCND1::IGH carrying progenitor germinal B-cell with subsequent cytogenetic aberrations contributes to the development of classic Hodgkin lymphoma1
102. Using cytogenomics to distinguish two types of renal cell carcinoma in a composite or collision tumor1
87. A tale of two aspirates: sequential pulls of bone marrow yield discordant results in hepatosplenic T-cell lymphoma1
79. Extraction of multiple analytes in liquid biopsy may improve the diagnosis of breast cancer1
47. Tumour-only NGS profiling: Application of data filters to identify candidate germline variants1
0.13950490951538